
TSE:TRI
This summary was created by AI, based on 36 opinions in the last 12 months.
Thomson Reuters Corp (TRI-T) is currently facing scrutiny due to fears that AI may disrupt its core legal and financial data services. Despite its strong fundamentals, including a solid balance sheet and consistent revenue performance, investor sentiment is cautious amid potential AI competition. While some experts highlight TRI's proprietary data as an essential asset that AI tools cannot easily replicate, others express concern over the company's competitive positioning moving forward. Many analysts suggest that TRI's valuation, although lower than past highs, remains elevated in the context of growth expectations. Ultimately, there is a general consensus that the stock, while presenting attractive opportunities for long-term investors, is undergoing a transitional phase marked by market volatility and shifting investor perceptions regarding its future performance in light of AI advancements.
Classic compounder, higher valuation. Narrative shifted around software. Lots of bad news priced in. Trades 21x forward PE, grows earnings at 10+% pretty consistently.
AI fears overblown. Stock's finding support. Bounced on news that it's working with Anthropic. Don't expect a V-shaped bounce, be patient.
Anthropic had announced an AI tool that could write legal briefs. There were worries this could displace TRI, which also was at a high PE before the drop. He hopes today is an inflection point where AI companies will partner with data providers which have unique, irreplaceable data. He hopes sentiment changes on the entire sector where they are beneficiaries and not disrupted by AI.
All of the Top Picks today are being tarred with the same software brush, with very little differentiation of what they do and how they do it.
Huge differentiator is its 3 end markets: lawyers, compliance professionals, and accountants. The data in all of its core product offerings is proprietary. Employs more than 3k legal and accounting professionals to curate this information.
Competitive advantage, including from Anthropic, is so difficult to replicate. In last few years, has already been incorporating AI into its products. Likely to maintain its moat, and perhaps deepen it further. He's never seen the valuation it's at, very attractive. Yield is 2.98%.
Piquing his curiosity in last weeks and months. Cut in half since last summer. Encapsulates all the consternation roiling around software vs. AI, and accelerated with the Anthropic release. Dominant franchise in law. Superficially, selloff is overdone.
While fears about AI disrupting are legitimate, companies can have proprietary moats on their data and networks. TRI owns 100 years of caselaw and subsequent analysis. Increasingly layering on AI tools. PE multiple not seen in years.
Once upon a time, he worked for them in Boston ;)
Falling knife at the moment. He's the kind of guy that when something gets expensive, he doesn't want to own it. When something sells off like this, his eyes get big and he sees opportunity. He doesn't see that yet. He'd have to do a lot more work to figure out whether to sell or hold. Sorry. It's not one he usually follows.
He'd leave it alone and let it settle. After 3-6 months if it stops going down, a new buyer can get interested in it.
Fourth-quarter revenue totaled $2.01 billion, representing a 5% increase from the prior year and 7% growth on an organic basis, while adjusted EBITDA came in at $777 million (an 8% gain with a 38.7% margin). For the full year, organic revenue expanded 7%, adjusted EBITDA climbed 6% to $2.94 billion (39.2% margin), and adjusted earnings per share reached $3.92. The company surpassed analyst expectations and raised its dividend by 10%. Subscription-based revenues, which made up 84% of fourth-quarter sales, increased 9% organically, and free cash flow jumped 38% to $581 million in the quarter. The Reuters division benefited from AI-driven products and content licensing agreements, achieving 5% organic growth, while the Global Print segment experienced an anticipated 6% contraction. Unlock Premium - Try 5i Free
Valuation had been overinflated. In major selloffs, sometimes concerns are overblown. A company like this has to reinvent itself over its lifespan. We're not quite sure how AI applications will play into software companies. Looks overdone, but you don't want to catch a falling knife.
If you want to start a position, dollar-cost-average in at times when stock's been hit a bit harder.
Pulled back with lots of other software names. Proprietary database for law, accounting, and healthcare. Topline growing high single digits, bottom line double digits. Enormous amount of free cashflow. Market's worried about AI. A neatly bundled one-stop solution for its subscribers.
Fantastic business model, trading ~20x PE. He's attracted to it, but likes what he owns already so wouldn't know what to sell to buy this one. Take a hard look at it.
Decent earnings print last quarter. Legal/professional side up 9% for organic growth, but print side is suffering from investment in Globe and Mail (organic growth down 4%). Slow print recovery, government cancellations, softer corporate sales momentum.
Business is solid. Decline of 15% recently. For most investors, decent time to add.
Software selloff is overdone. AI won't be that quick to replace a company like this. Already incorporates AI in its programs. Data is proprietary.
If you got in a couple of weeks ago, hold on. His firm is looking to get in.